JPMorgan Chase & Co. Acquires 43,470 Shares of Celldex Therapeutics, Inc. (NASDAQ:CLDX)
JPMorgan Chase & Co. grew its holdings in Celldex Therapeutics, Inc. (NASDAQ:CLDX – Free Report) by 103.3% in the fourth quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor owned 85,545 shares of the biopharmaceutical company’s stock after buying an additional 43,470 shares during the quarter. JPMorgan […]
JPMorgan Chase & Co. grew its holdings in Celldex Therapeutics, Inc. (NASDAQ:CLDX – Free Report) by 103.3% in the fourth quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor owned 85,545 shares of the biopharmaceutical company’s stock after buying an additional 43,470 shares during the quarter. JPMorgan […]